Background: Due to the chronic processes of rheumatological diseases, patients’ biopsychosocial effects are revealed.

Objectives: The aim of this study is to evaluate the biopsychosocial status of individuals diagnosed with psoriatic arthritis; to examine the relationship between quality of life, emotion - status and functionality.

Methods: 105 individuals were included in the study. To evaluate the biopsychosocial situation, BETY-BQ (Bilişsel Egzersiz Terapi Yaklaşimi – Biopsychosocial Questionnaire)(1); Psoriatic Arthritis Quality of Life (PsAQoL) Scale to assess quality of life; For the emotion-status assessment; Hospital Anxiety and Depression Scale (HADS-A, HADS-D); Health Assessment Questionnaire (HAQ) was used for functionality. Pearson Correlation Analysis was used in statistical analysis.

Results: Descriptive data of the individuals participating in the study were recorded (Table 1).While BETY-BQ was highly correlated with PSAQoL Scale(r = 0.826, p <0.001), moderate correlations were found with HADS-A and HADS-D (HADS-A (r = 0.618, p <0.001), HADS-D (r = 0.507, p <0.001)). Low correlation was found between BETY-BQ and HAQ (r = 286, p = 0.003) (Table 2).

Conclusion: In this study, it was found that BETY-BQ is a scale that can be used in total to evaluate the quality of life, emotion-status level and functionality of individuals diagnosed with PsA. It was thought that BETY-BQ could be considered and preferred by clinicians when individuals with PsA should be evaluated from a biopsychosocial point of view.

References:

[1] Unal E, Arin G, Karaca Nb, Kiraz S, Akdogan A, Kalyoncu U, et al. Development of a quality of life measurement for rheumatic patients: item pool construction Journal of Exercise Therapy and Rehabilitation. 2017; 4 (2): 67-75.

Disclosure of Interests: Senem Bulut: None declared, Edibe Ünal: None declared, Aykut Özçadirci: None declared, Umut Kalyoncu Consultant of: Abbvie, Amgen, Janssen, Lilly, Novartis, UCB